Showing results (91-100 of 318) with videos related to
Sort By:
Pageof 32
Molecular Cell|October 16, 2007
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, et al.Plos Medicine|February 15, 2008
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndromeBenjamin L Ebert, Naomi Galili, Pablo Tamayo, et al.Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.Blood|June 27, 2012
L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathwayElspeth M Payne, Maria Virgilio, Anupama Narla, et al.Cell|January 27, 2007
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stressZuzana Tothova, Ramya Kollipara, Brian J Huntly, et al.JAMA Cardiology|June 9, 2021
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular EventsRomit Bhattacharya, Seyedeh Maryam Zekavat, Md Mesbah Uddin, et al.The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.Blood|October 5, 2014
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasmsEdwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, et al.Cell|January 27, 2007
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasisJi-Hye Paik, Ramya Kollipara, Gerald Chu, et al.Pageof 32